mBIOTA Elemental Diet Recognized as the 2026 Food Science Innovation of the Year

mBIOTA’s palatable elemental diet is honored by the BioTech Breakthrough Awards 
for revolutionizing GI care

The 2026 Biotech Breakthrough Awards recognize innovations from established biotechnology and life sciences companies, including Phathom Pharmaceuticals, Schrödinger and Thermo Fisher Scientific, while previous recipients include global pharmaceutical and life sciences leaders AstraZeneca, Johnson & Johnson, Pfizer and Amgen. Among this year’s honorees, mBIOTA Labs stands out by demonstrating how patient-centered innovation can advance an established area of clinical care. In just three years on the market, mBIOTA is helping redefine what elemental nutrition can offer patients, bringing together scientific research, formula innovation, and a focus on improving the patient experience.

SANTA MONICA, Calif., November 5, 2026 – mBIOTA Labs, an emerging medical food company advancing the science and use of medical nutrition for the management of gastrointestinal (GI) conditions, today announced mBIOTA Elemental™ Diet has been recognized as the 2026 Food Science Innovation of the Year by the BioTech Breakthrough Awards. This program celebrates the innovators transforming the global biotechnology and life sciences landscape with breakthrough technology.

mBIOTA Elemental Diet helps manage chronic GI conditions such as small intestinal bacterial overgrowth (SIBO), irritable bowel syndrome (IBS), and inflammatory bowel diseases (IBD). The medical food launched in 2024 as the first palatable, clinically proven elemental diet that may be preferable to patients seeking non-pharmaceutical options and improves upon the patient experience of traditional elemental diets. Through its proprietary Amino Taste Modification Technology, mBIOTA Elemental solves for taste as a historical barrier to compliance, as traditional elemental diets were not intended for oral consumption. This innovative solution now offers patients living with gastrointestinal (GI) disorders a science-backed option to consider on their path to finding symptom relief. 

Now in its third year on the market, mBIOTA Elemental has supported thousands of patients across the U.S. and internationally. mBIOTA developed a network of over 2,000 healthcare professionals that trust mBIOTA Elemental in 2025 and has expanded its body of clinical research since its launch with abstract presentations at prestigious GI conferences, including  Digestive Disease Week, American College of Gastroenterology’s Annual Meeting, and United European Gastroenterology (UEG) 2026 Week. mBIOTA continues to trailblaze medical food science innovations for the elemental diet by expanding available flavor choices without compromising the elemental formula or its efficacy, most recently launching the Lemon Ginger flavor in September 2026.

“The elemental diet went largely unused for over 50 years due to its unpleasant taste and consequently low patient compliance. Receiving this recognition from the BioTech Breakthrough Awards is a testament to the impact of the innovation we’ve achieved,” said Nicola Wodlinger, CEO of mBIOTA Labs. “As a science-backed company, we’re committed to expanding the body of research behind elemental diets across new disease states and finding ways to help more patients improve their quality of life, too. ”

Fellow 2026 BioTech Breakthrough Award recipients include Phathom Pharmaceuticals, Schrödinger and Thermo Fisher Scientific, while previous recipients include global pharmaceutical and life sciences leaders AstraZeneca, Johnson & Johnson, Pfizer and Amgen.

“mBIOTA Labs, a patient-centered medical food company, has redefined the therapeutic nutrition landscape. A quarter of Americans live with GI conditions and many suffer debilitating symptoms that impact their work, relationships, and quality of life. Antibiotics show only around a 50% efficacy rate. 

Though elemental diets have been effective at managing these diseases, taste has been a challenge to compliance,” said Bryan Vaughn, Managing Director, BioTech Breakthrough. “With its proprietary Amino Taste Modification Technology, mBIOTA has successfully created the first and only clinically proven and palatable ED, successfully developing three flavors without any artificial flavors or sweeteners. We’re awarding mBIOTA with ‘Food Science Innovation of the Year.’” 

The full list of BioTech Breakthrough winners is available here. 

####

About mBIOTA Labs

mBIOTA Labs is an evidence-led medical nutrition company advancing the science and use of elemental nutrition. Used in clinical care for decades, elemental diets provide essential nutrients in their simplest forms, allowing them to be absorbed with minimal digestion and supporting the nutritional management of a range of chronic gastrointestinal (GI) conditions. Founded from firsthand patient experience to provide a scientifically validated alternative to pharmaceuticals for chronic GI conditions. mBIOTA works with leading clinicians, researchers, and food scientists to set a higher standard for how elemental nutrition is studied, formulated, and experienced.

Its flagship medical food, mBIOTA Elemental™, was developed to address one of the category’s longstanding barriers: tolerability. Through clinical research, practical innovation, and patient-centered support, mBIOTA is working to make this established clinical approach more viable, accessible, and better understood in modern digestive care. To learn more, visit mBIOTA.com.

About BioTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Immunology, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughAwards.com 

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.